Speaker illustration

Doctor Mohamed Salah Abdelghani

Hamad Medical Corporation Heart Hospital, Doha (Qatar)

Member of:

European Society of Cardiology
Heart Failure Association

Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Statin therapy: clinical role and current challenges


Unforeseen rare complication of percutaneous coronary intervention.

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session: Nightmare at the cath lab


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb